Published Date: 7 July 2022
Tender Status: complete
Tender Opening Date: n/a
Tender Closing Date: 4 May 2022
Award Date: 5 May 2022
Contract Start Date: 5 May 2022
Contract End Date: 5 May 2022
Contract is suitable for SMEs: Yes
Contract is suitable for VCSEs: No
Official Journal of the European Union (OJEU) Contract Type: Services
The Medicines Discovery Catapult will conduct an in vivo 18F imaging and toxicity study in naive and cancer xenograft bearing mice of our HER2 targeting apoferritin anti-cancer drug delivery platform. This study is funded under the MRC Confidence in Concept funding to the University (Project code: RA05P6. We have been collaborating with a separate division of MDC using the same cell lines in vitro (SKBR3 and BT474) in super resolution microscopy studies to determine the uptake of the apoferritin system at a single apoferritin/cell level.
Contact name: Guy Wilding
Address: Kings Meadow Campus, Lenton Lane
NOTTINGHAM
NG72NR
England
Telephone: 0115 951 5151 ext 15151
Fax: n/a
Email: [email protected]
Price Range: n/a
